In accordance with this fact, McCray and Parrish (2004) suggest that doses of 6070 g/day (45 tablespoons, approximately 500600 cal) spread out throughout the day are generally tolerated
What this test evaluates Blood concentration of CEA (ng/mL) Tumor-related antigen activity, particularly from gastrointestinal sources Why a CEA test is ordered Baseline and follow-up monitoring in people with a history of colorectal cancer Detection of recurrence or progression after surgery, chemotherapy, or radiation Assessment of treatment response Supportive evaluation when symptoms or imaging raise concern for malignancy How CEA levels are interpreted CEA is not cancer-specific Elevated levels can be seen with: Colorectal cancer Other cancers (gastric, pancreatic, lung, breast) Smoking Inflammatory bowel disease Liver disease Pancreatitis or infection For this reason, CEA is not used as a screening test in healthy individuals What results may show Low or stable CEA: generally reassuring, especially when consistent over time Rising CEA trend: may suggest recurrence or active disease and usually prompts further evaluation Isolated mild elevation: often nonspecific
While this is just a small sampling of the community, I wanted to share the results beyond our community because they echo other small studies reporting potential benefits for HS patients and support the case for further research on HS and GLP-1s
UV rays, in particular, can cause premature aging by triggering the production of free radicals, which damage cellular structures and DNA
